Nachrichten zur Johnson & Johnson Aktie

JNJs Combo Therapy Shows Strong Phase III Efficacy in Prostate Cancer

Johnson & Johnsons niraparib combo significantly delays prostate cancer progression in HRR-altered patients with strong phase III data.…

Johnson & Johnson (JNJ) Stock Dips While Market Gains: Key Facts

Johnson & Johnson (JNJ) closed at $154.42 in the latest trading session, marking a -0.63% move from the prior day.…

Addiction Disorders Drugs Market Analysis and Forecast to 2030: A $39.5 Billion Opportunity Led by Pfizer, Johnson & Johnson, and Indivior

Dublin, June 02, 2025 (GLOBE NEWSWIRE) -- The "Addiction Disorders Drugs Market by Indication, Product Type, Route of…

Better Dividend Growth ETF: Vanguard Dividend Appreciation ETF or iShares Core Dividend Growth ETF

Dividend growth stocks can be powerful investments. Hartford Funds and Ned Davis Research dug into the data on stocks based…

3 Elite High-Yield Dividend Stocks Down 8% to 27% That Have Hiked Their Payouts for More than 50 Years in a Row

Some of the best dividend stocks in the world are on sale right now. Shares of Federal Realty Investment Trust…

Johnson & Johnson (JNJ) Stock Moves -0.54%: What You Should Know

In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $152.43, denoting a -0.54% change from…

1 Top Dividend Stock to Buy for a Lifetime of Passive Income

There are hundreds of dividend stocks on the market, but they dont all offer the same level of security. Some…

Johnson & Johnson: Raising My Price Target Amid Stable EPS Growth

…

Investing for Passive Income? Heres What History Says About the Stability of Dividend King Stocks.

When we think of stock market investing, we often think of choosing stocks we hope will soar, and thats definitely…

Generating Passive Income: 3 Top Dow Dividend Stocks to Buy for 2025 and Beyond

The Dow Jones Industrial Average is an iconic stock market index. It tracks the performance of 30 of the countrys…

Elon Musk Commits to Tesla. Is That a Good Thing?

In this podcast, Motley Fool analyst Jason Moser and host Ricky Mulvey discuss: Investing in companies with a "singular" leader, like…

Johnson Matthey Plc (JMPLF) Q4 2025 Earnings Call Transcript

…

Johnson & Johnson (JNJ) Declines More Than Market: Some Information for Investors

In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $152.51, denoting a -0.44% change from…

2 Stocks That Turned $1,000 Into More Than $8,000 in 10 Years to Buy and Hold

The average stock market return over the past few decades (without accounting for inflation) is around 10%. That makes broader…

Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know

Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth…

3 Magnificent Stocks That Are Passive Income Machines

Make money without even trying: Thats what passive income is all about. But good investment alternatives are required to make…

Want Decades of Passive Income? Buy and Forget These 3 ETFs

Investing in the stock market isnt all about trying to find the next big growth stock or swinging for the…

Billionaire CEO Jamie Dimon Says a Recession Isnt "Off the Table at This Point," Despite Lowering Tariffs. 5 Ways to Help Protect Your Stock Portfolio in Any Market Environment.

In recent days, investors have breathed a sigh of relief. After weeks of concerns about the impact of President Donald…

Heres Why Johnson & Johnson (JNJ) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.…

Why Is Johnson & Johnson (JNJ) Down 4.9% Since Last Earnings Report?

Johnson & Johnson (JNJ) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings…

Pfizer, Merck, Johnson & Johnson to lose billions to Trumps latest executive order

The President is scheduled to sign an Executive Order on Monday to upend the entire pharmaceutical industry.…

Tryptamine Therapeutics new chairman to lead next phase of clinical growth

Tryptamine Therapeutics Ltd has named former Johnson & Johnson executive Herwig Janssen as its new non-executive chairman, marking a significant…

3 "Top Picks" From Wall Street That Are Magnificent Buys Right Now

UBS analyst Amit Mehrotra recently added Honeywell International (NASDAQ: HON) to his list of "top picks," which also includes industrials…

J&Js skin disease drug meets main goal in late-stage study

Johnson & Johnson said on Friday its experimental psoriasis drug met the main goal in a late-stage study on patients…

Johnson Controls Q2 Earnings & Revenues Top Estimates, Increase Y/Y

JCIs fiscal second-quarter revenues increase 1.4% year over year, driven by strength in the HVAC & controls businesses.…

2 Stocks I Cant Wait to Buy During the Next Market Correction

Investors never know when the next market correction -- a drop of from 10% to 20% in an index --…

Here Are All the Dividend Kings Beating the S&P 500 in 2025 -- and the 2 That Are the Best Stocks to Buy Now

The S&P 500 has bounced back somewhat after sinking nearly 19% below its previous high following President Trumps "Liberation Day"…

If You Invested $10K In Johnson & Johnson Stock 10 Years Ago, How Much Would You Have Now?

Johnson & Johnson (NYSE:JNJ) engages in the research and development, manufacture, and sale of various products in the healthcare field…

3 Dividend Stocks You Can Be Comfortable Buying and Holding, Even in a Recession

The broader stock market indexes have recovered nicely in recent weeks. However, some investors may still fear that the impact…

Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?

Investors often view Pharmaceutical stocks as safe havens during periods of market turbulence. Stock market volatility or even economic downturns…

Johnson Outdoors sees strong demand for new products despite market challenges

…

Johnson Outdoors Inc. (JOUT) Q2 2025 Earnings Call Transcript

…

Countdown to Johnson Controls (JCI) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS

Get a deeper insight into the potential performance of Johnson Controls (JCI) for the quarter ended March 2025 by going…

2 Stocks Down 89% and 15% to Buy Right Now

A third of the year is now over, and the stock market has seen incredible levels of volatility across the…

Goldman Sachs updates conviction lists: Adds Johnson & Johnson and Axis Bank By Investing.com

Goldman Sachs updates conviction lists: Adds Johnson & Johnson and Axis Bank…

Top Stock Reports for Amazon.com, Johnson & Johnson & Cisco Systems

Todays Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Johnson & Johnson (JNJ) and…

Trump to tout US investments from Nvidia, J&J, Hyundai, Toyota

CEOs and other executives from Nvidia , Johnson & Johnson , Toyota Motor , Eli Lilly and SoftBank Group are…

Trump to Tout US Investments From Nvidia, J&J, Hyundai, Toyota

By David Shepardson WASHINGTON (Reuters) -CEOs and other executives from Nvidia, Johnson & Johnson, Toyota Motor, Eli Lilly and SoftBank…

Nvidia, Eli Lilly Among CEOs to Tout US Investments With Trump

Chief executive officers from Nvidia Corp., Johnson & Johnson, Eli Lilly & Co., General Electric Co. and SoftBank Group Corp.…

Want to Avoid the "Magnificent Seven" and Generate Passive Income? This Vanguard ETF May Be for You

The "Magnificent Seven" -- Apple, Microsoft, Nvidia, Amazon, Alphabet, Meta Platforms, and Tesla -- took the market by storm in…

Johnson & Johnson’s TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk papillary NMIBC

First results from SunRISe-1 (Cohort 4) show strong disease-free survival rates across high-grade papillary tumours, demonstrating the potential for bladder…

Johnson & Johnson’s TAR-200 monotherapy demonstrates highest complete response rate reported to date with sustained clinical benefits in patients with certain types of bladder cancer

Phase 2b SunRISe-1 study shows more than 82 percent of patients achieved complete response (CR) with more than half of…

These 2 Top Dividend Stocks Are Making Moves to Avoid the Impact of Tariffs: Are They Buys?

President Donald Trumps macroeconomic policies are taking center stage on Wall Street. The 47th U.S. president has decided to implement…

Johnson & Johnson’s Rare AAA Rating No Longer at Risk, S&P Says

Johnson & Johnson, one of the few remaining companies with a top credit rating, is no longer at risk of…

3 Dividend Kings That Have Raised Their Payouts in 2025

If you want to collect a lot of dividend income, its important to focus on more than just a stocks…

Johnson & Johnson Aktie: Nicht gegen Zölle immun

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI),…

2 Recession-Proof Stocks to Buy With a Better Credit Rating Than the U.S. Government

In 2011, following the difficulty caused by the Great Recession, S&P Global Ratings (formerly Standard & Poors) downgraded the long-term…

The Best Value ETF to Invest $500 in Right Now

Lets say you have $500 to invest and youre wondering where to park it. Thats a great position to be…

3 Top Dividend Stocks Yielding Over 3% to Buy With $500 Right Now

Dividend stocks can be fantastic investments. The best ones pay an attractive and growing stream of dividend income while also…

2 No-Brainer Vanguard ETFs to Buy With $1,000 Right Now

One of my favorite ways to invest is through exchange-traded funds (ETFs) because they offer you to exposure to many…